Skip to main content

Google Translate Widget by Infofru

Author Site Reviewresults

Bibliography

Publications

  1. Sykes MP, Salem P, Joffe B. Topical 5-fluorouracil: variability of effective dosage and duration of reaction. J Am Geriatr Soc 1971; 12:977-982.
  2. Salem PA. Pulmonary changes and bleomycin. Cancer Bull 1971(Jul-Aug);23(4):68-69.
  3. Hart JS, Ho DH, George SL, Salem P, Gottleib JA, Frei E 3rd. Cytokinetic and molecular pharmacology studies of arabinosylcytosine in metastatic melanoma. Cancer Res 1972; 32:2711-2716.
  4. Luna MA, Bedrossian CW, Lichtiger B, Salem PA. Interstitial pneumonitis associated with bleomycin therapy. Am J Clin Pathol 1972(Nov);58(5):501-510.
  5. Salem P. The rational approach to the cancer patient. (Editorial) J Med Liban 1972; 25:7-9.
  6. Salem PA, Omura G, Clarkson B. Clinicopathological correlations in acute leukemia. Chapter in the proceedings of the Arab Middle East Medical Conference, Syria 1974: pp 221-243.
  7. Salem PA. The multi-disciplinary approach to cancer. J Med Liban 1975;28(1):5-8.
  8. Salem PA. Advances in cancer chemotherapy. J Med Liban 1975;28(1):9-24.
  9. Hajj A and Salem P. Staging in Hodgkin's disease. Techniques and impact on therapy. J Med Liban 1975; 28:79-87.
  10. Salem PA, Nassar V, Hajj A, Balikian G, Alami S, Shamaa M, Salem A. [Clinical Statement. What is called “Mediterranean Lymphoma” at the Hospital Center of the American University in Beirut]. J Med Liban 1975;28(2):215-224.
  11. Kaufman R, Salem P, Wittes RE. Responsiveness to endocrine manipulation in breast cancer after "prophylactic" castration. J Surg Oncol 1977; 9:39-43.
  12. Salem PA, Bodey GP, Burgess MA, Murphy WK, Freireich EJ. A phase I study of pyrazofurin. Cancer 1977(Dec);40(6):2806-2809.
  13. Salem PA, Nassar VH, Shahid MJ, Hajj AA, Alami SY, Balikian JB, Salem AA. "Mediterranean abdominal lymphoma," or immunoproliferative small intestinal disease. Part I: clinical aspects. Cancer 1977(Dec);40(6):2941-2947.
  14. Salem PA. Oncology overview. Monograph. Selected abstracts on Platinum coordination complexes as anticancer agents. US Department of Health, Education, and Welfare, Service of the International Cancer Research Data Bank (ICRDB) 1977(Oct).
  15. Yap HY, Salem P, Hortobagyi GN, Bodey GP Sr, Buzdar AU, Tashima CK, Blumenschein GR. Phase II study of cis-dichlorodiammineplatinum (II) in advanced breast cancer. Cancer Treat Rep 1978; 62:405-408.
  16. Salem P, Hall SW, Benjamin RS, Murphy WK, Wharton JT, Bodey GP. Clinical phase I-II study of cis-dichloro-diammineplatinum (II) given by continuous Iv infusion. Cancer Treat Rep 1978; 62:1553-1555.
  17. Nassar VH, Salem PA, Shahid MJ, Alami SY, Balikian JB, Salem AA, Nasrallah SM. “Mediterranean abdominal lymphoma” or immunoproliferative small intestinal disease. Part II: pathological aspects. Cancer 1978(Apr);41(4):1340-1354.
  18. Loo TL, Hall S, Salem PA, Benjamin R, Lu K. Clinical pharmacological and toxicological studies of cis-diamminedichloro-platinum (II) by continuous intravenous infusion. Biochemie 1978; 60:957-960.
  19. Nassar NT, Zurayk HC, Salem PA. Smoking patterns among university students in Lebanon. J Am Coll Health Assoc 1980(Apr);28(5):283-285.
  20. Issa PY, Salem PA, Brihi E, Azoury RS. Eosinophilic granuloma with involvement of the female genitalia. Am J Obstet Gynecol 1980(Jul 1);137(5):608-612.
  21. Salem PA, Jabboury KW, Khalil MF. Severe nephrotoxicity: a probable complication of cis-dichlorodiammineplatinum (II) and cephalothin-gentamicin therapy. Oncol 1982;39(1):31-32.
  22. Salem PA, Tabry I, Parsi M, Brihi E. Histiocytic lymphoma presenting with portal hypertension and bleeding esophageal varices: a case report. J Surg Oncol 1982(May);20(1):37-40.
  23. Abdel Karim FW, Ayash RE, Allam C, Salem PA. Pulmonary fibrosis after prolonged treatment with low-dose cyclophosphamide. A case report. Oncology 1983;40(3):174-176.
  24. Mooradian AD, Allam CK, Khalil MF, Salti I, Salem PA. Anaplastic transformation of thyroid cancer: report of two cases and review of the literature. J Surg Oncol 1983(Jun);23(2):95-98.
  25. Penta JS, Muggia FM, Salem PA. Cisplatin in cancer therapy -- Optimization of treatment regimens and toxicity protection. Chapter 6 in Cancer Chemotherapy I. Muggia FM, Editor. Martinus Nijhoff, The Hague 1983; pp 149-169.
  26. Salem P, Khalyl M, Jabboury K, Hashimi L. Cis-diamminedichloroplatinum (II) by 5-day continuous infusion. A new dose schedule with minimal toxicity. Cancer 1984; 53:837-840.
  27. Salem PA. Systemic therapy of bladder cancer. Prog Clin Biol Res 1984;162B:95-105.
  28. Hashimi LA, Khalyl MF, Salem PA. Supraventricular tachycardia. A probable complication of platinum treatment. Oncology 1984;41(3):174-175.
  29. Salem PA, Hashimi L, Anaissie E, Khalyl M, Allam C. Primary intestinal lymphoma of adults in the Middle East. J Chemioterapia 1985; 43:1352.
  30. Anaissie E, Geha S, Allam C, Jabbour J, Khalyl M, Salem P. Burkitt's lymphoma in the Middle East. A study of 34 cases. Cancer 1985; 56:2539-2543.
  31. Salem PA, Habboubi N, Anaissie E, Brihi ER, Issa P, Abbas JS, Khalyl MF. Effectiveness of cisplatin in the treatment of anal squamous cell carcinoma. Cancer Treat Rep 1985(Jul-Aug);69(7):891-893.
  32. Anaissie E, Geha S, Allam C, Jabbour J, Khalyl M, Salem P. Burkitt's lymphoma in the Middle East. In Burkitt's Lymphoma: A Human Cancer Model. Lenoir GM, O'Connor GT, Olweny CLM, Editors. IARC Scientific Publications, Lyon. 1985; 60:129-134.
  33. Salem PA, El-Hashimi L, Anaissie E, Khalyl M, Allam C. Immuno-proliferative small intestinal disease. Chapter in Malignant Lymphomas and Hodgkin's Disease: Experimental and Therapeutic Advances. Cavalli F, Bonadonna G, Rozencweig M, Editors. Martinus Nijhoff Publishing 1985; pp 269-277.
  34. Salem P, Khalyl M, Jabboury K, Hashimi L. The 5-day continuous infusion of cis-platinum: An update on toxicity pattern. Chapter in Clinical Applications of Continuous Infusions, Chemotherapy, and Concomitant Radiation Therapy. Rosenthal CJ and Rotman M, Editors. Plenum Press, New York 1985: pp 101-105.
  35. Salem P, Anaissie E, Allam C, Geha S, Hashimi L, Ibrahim N, Jabbour J, Khalyl M. Non-Hodgkin's lymphomas in the Middle East. A study of 417 patients with emphasis on special features. Cancer 1986; 58:1162-1166.
  36. Salem PA. Non-Hodgkin's lymphomas. Management strategy and future research. J Med Liban 1986;36(3):107-115.
  37. Salem P, El-Hashimi L, Anaissie E, Geha S, Habboubi N, Ibrahim N, Khalyl M, Allam C. Primary small intestinal lymphoma in adults. A comparative study of IPSID versus non-IPSID in the Middle East. Cancer 1987; 59:1670-1676.
  38. Shikhani A, Samara M, Allam C, Salem PA, Lenhard R. Primary lymphoma in the salivary glands: report of five cases and review of the literature. Laryngoscope 1987; 97:1438-1442.
  39. Salem PA. Mediterranean Abdominal Lymphoma (Immunoproliferative Small Intestine Disease). Chapter 36 in Manual of Adult and Paediatric Medical Oncology. Monfardini S, Brunner K, Crowther D, Eckhardt S, Olive D, Tenneberger S, Veronesi A, Whitehouse J, Wittes R, Editors. Springer-Verlag, Inc, New Jersey 1987: pp 375-377.
  40. Ibrahim NK, Khouri FP, Salem PA. VP-16-based regimen in adult acute nonlymphoblastic leukemia. Oncology 1988;45(1):21-23.
  41. Kim EE, Abello R, Wallace S, Coan J, Salem PA. Gated MRI imaging of malignant cardiac tumors. Mag Resonance Imaging 1988; 6:129.
  42. Kim EE, Wallace S, Abello R, Coan JD, Ewer MS, Salem PA, Ali MK. Malignant cardiac fibrous histiocytomas and angiosarcomas: MR features. J Comput Assist Tomogr 1989(Jul-Aug);13(4):627-632.
  43. Zakhem A, Aftimos G, Kreidy R, Salem P. Malignant struma ovarii: report of two cases and selected review of the literature. J Surg Oncol 1990; 43:61-65.
  44. Mavligit GM, Zukiwski AA, Gutterman JU, Salem P, Charnsangavej C, Wallace S. Splenic versus hepatic artery infusion of interleukin-2 in patients with liver metastases. J Clin Oncol 1990;8:319-324.
  45. Mavligit GM, Zukiwski AA, Salem PA, Lamki L, Wallace S. Regression of hepatic metastases from gastrointestinal leiomyosarcoma after hepatic arterial chemoembolization. Cancer 1991(Jul 15);68(2):321-323.
  46. Karr RA, Best CG, Salem PA, Toth, BB. Synovial sarcoma metastatic to the mandible: report of two cases. J Oral Maxillofac Surg 1991(Dec);49(12):1341-1346.
  47. Gonzalez R, Salem P, Bunn PA Jr, Zukiwski AA, Lamb R, Benjamin RS, Spitler L, Wedel N, Robinson WA. Single-dose murine monoclonal antibody ricin A chain immunotoxin in the treatment of metastatic melanoma: a phase I trial. Mol Biother 1991; 3:192-196.
  48. Salem PA. Mediterranean abdominal lymphoma. A new pathological classification. Chemotherapia 1992(Aug).
  49. Salem PA. Evolution of chemotherapy in the treatment of sarcomas. Chemotherapia 1992(Aug).
  50. Jones D, Levin B, Salem P. Primary Small Intestinal Lymphomas. Chapter 69 in Gastrointestinal Disease: Pathophysiology/ Diagnosis/ Management, 5th Edition. Sleisenger MH and Fordham JS, Editors; Scharschmidt BF and Feldman M, Associate Editors. WB Saunders Company 1993: pp 1378-1392.
  51. Kim EE, Cho J-S, Salem P, Ro JY, Mountain CF. Case Report: Mediastinal synovial sarcoma. Cancer Bulletin 1993; 45:370-372.
  52. Salem P and Jones, D. Treatment of Malignant Neoplasms of the Mucosa-Associated Lymphoid Tissues (MALT). Chapter 47 in The Non-Hodgkin's Lymphomas, 2nd Edition. Ian Magrath, Editor. Arnold 1997: pp 989-1005.
  53. Salem PA. Breast Cancer: Advances in Early Detection and Prevention. Medical Interface 1996(Aug);9(8).
  54. Salem PA. Recapturing compassion in medicine: A book review. In Medicine: Preserving the Passion in the 21st Century, 2nd edition. Texas Medicine 2005(Sep): pp13-14.
  55. Salem PA and Estephan FF. Immunoproliferative small intestinal disease: current concepts. Cancer J 2005(Sep-Oct);11(5):374-382.
  56. Salem PA. Lymphoma: diagnosis and treatment. St. Luke’s Cancer Program 2007 Annual Report. 2007(Dec).
  57. Mach CM, Kim J, Soibam B, Creighton CJ, Hawkins SM, Zighelboim I, Goodfellow P, Gunaratne PH, Odunsi K, Salem PA, Anderson ML. Novel MicroRNAs regulating proliferation and apoptosis in uterine papillary serous carcinomas. Cancer Lett 2013(Jul 28);335(2):314-322.
  58. Salem PA, Jabboury K, Stenoien R, Wheeler T, Valerio MR. Immune checkpoint inhibitors combined with chemotherapy and targeted therapy yield high remission rates in advanced cancer diseases. Trends in Cancer Research. Vol 15; Dec 2020; Pgs 49-62.

Presentations and Abstracts

  1. Kaufman RJ and Salem PA. Recurrent mammary cancer - endocrine management after "prophylactic castration." 10th Intl Cancer Cong, Abstract #835, 6:517, 1970.
  2. Salem PA and Sykes M. Effect of topical 5-fluorouracil on normal skin. 10th Intl Cancer Cong, Abstract #798, 6:493, 1970.
  3. Hart J, Ho D, Salem PA, Frei E. Clinical and kinetic evaluation of continuous 5-day Ara-c in melanoma. Am Assoc Cancer Res, Abstract #401, 13:101, 1972.
  4. Salem PA, Hajj A, Shahid M, Azzam S, Alami S. Experience with exploratory laparotomy in Hodgkin's disease in the Middle East. 11th Intl Cancer Cong, Part 1-2:276, 1974.
  5. Salem PA and Hajj A. Role of the hospital-based cancer registry: The experience of the American University of Beirut Hospital. 6th Scien Mtg Leb Assoc for Advancement of Science, Beirut, Proceedings of the meeting, p 291, 1974.
  6. Salem PA, Hajj A, Alami S, Nassar V. Mediterranean abdominal lymphoma. 3rd Intl Symp on Detection and Prevention of Cancer, New York, 1976.
  7. Salem PA, Sinno B, Hajj A, Kuzhaya S. High dose intermittent therapy with DTIC in melanoma and other solid tumors. Am Assoc Cancer Res, Abstract #462, 17:116, 1976.
  8. Salem PA and Nassar VH. Primary small intestine lymphoma with malabsorption -- A distinct clinicopathological entity. Am Soc Clin Oncol, Abstract #C-138, 17:271, 1976.
  9. Salem PA and Parsi M. Combination chemotherapy in the treatment of inflammatory breast cancer. Am Assoc Cancer Res, Abstract #82, 18:21, 1977.
  10. Salem PA and Risk G. Hepatic arterial combination chemotherapy in the treatment of primary malignant lymphomas in the liver. (Abstract) Am Soc Clin Oncol, 18:268, 1977.
  11. Salem PA, Bodey G, Freireich E. Current clinical status of cis-dichlorodiammineplatinum II (DDP) in cancer therapy. Annual Meeting, Texas Medical Assoc, 1977.
  12. Salem PA and Tarraf F. Lebanon's experience with a hospital-based cancer registry. 1st Middle East Cancer Conference, Egypt, 1977.
  13. Salem PA, Nassar V, Hajj A, Salem A, Alami A. The role of staging laparotomy in the total management of primary small intestinal lymphoma. 1st Middle East Cancer Conference, Egypt, 1977.
  14. Hall, Salem PA, Benjamin R, Lu K, Loo TL, Murphy W, Wharton JT, Bodey G. Continuous intravenous infusion (civi) of cis-dichlorodiammine-platinum II (DDP): A clinical toxicologic and pharmacologic study. Am Soc Clin Oncol, Abstract #C-441, 19:417, 1978.
  15. Salem PA, Parsi M, Tavelian S. Intra-hepatic arterial combination chemotherapy with adriamycin, cyclophosphamide and 5-fluorouracil in the treatment of metastatic liver disease from breast cancer. Am Assoc Cancer Res, Abstract #45, 19:12, 1978.
  16. Salem PA, Haddad F, Brihi E, Issa P. Treatment of glioblastoma multiforme with CCNU and brain irradiation. Am Soc Clin Oncol, Abstract #C-56, 19:320, 1978.
  17. Salem PA. Problems related to the study of primary small intestinal lymphomas in the Middle East. (Abstract) 3rd Intl Symp of Oncol, Tehran, 1978.
  18. Salem PA, Nassar V, Hajj A, Alami S, Salem A. Mediterranean abdominal lymphoma -- the experience of the American University of Beirut. 12th Intl Cancer Cong, Abstract #W62/6, 12:954, 1978.
  19. Hajj A, Salem PA, Nassar V, Issa P, Brihi E, Salem A. Survival of patients with Mediterranean abdominal lymphoma. 12th Intl Cancer Cong, Abstract #W61/19, 12:949, 1978.
  20. Salem PA, Mouradian S, Badran G. Combination chemotherapy in the treatment of advanced Mediterranean abdominal lymphoma. Am Soc Clin Oncol, Abstract #C-109, 20:317, 1979.
  21. Salem PA, Jabboury K, Khalyl M. Cis-dichlorodiammineplatinum by 5-day continuous infusion-toxicity pattern. Am Assoc Cancer Res, Abstract #336, 20:84, 1979.
  22. Salem PA, Jabboury K, Khalyl M. Further studies with cis-dichlorodiammineplatinum as a continuous 5-day infusion. Am Assoc Cancer Res, Abstract #716, 21:179, 1980.
  23. Salem PA, Nassar V, Alami S, Jabboury K, Khalyl M. Immuno-proliferative small intestinal disease -- A potentially preventable disease. 4th Intl Symp on Prevention and Detection of Cancer, 3:448, 1980.
  24. Salem PA, Jabboury K, Hashimi L, Khalyl M. Preliminary studies with vindesine. (Abstract) Am Soc Clin Oncol, 22:435, 1981.
  25. Salem PA, Khalyl M, Rizk G, Jabboury K, Hashimi L. Intra-hepatic artery infusion chemotherapy with cis-platinum in the treatment of metastatic liver from breast cancer. (Abstract) Am Assoc Cancer Res, 22:191, 1981.
  26. Salem PA, Nassar V, Allam C, Alami S, Salem A, Jabboury K, Hashimi L, Khalyl M. Immunoproliferative small intestinal disease -- A new and distinct form of malignant lymphoma. Intl Conf on Malignant Lymphoma -- Current Status and Prospects, Lugano, 1981.
  27. Salem PA, Nassar V, Allan C, Salem A, Jabboury K, Hashimi L, Khalyl M. Mediterranean abdominal lymphoma -- An update. (Abstract) 13th Intl Cancer Conf, Seattle, 1982.
  28. Hashimi L, Allam C, Khalyl M, Issa P, Brihi E, Salem PA. Primary gastrointestinal lymphomas -- The experience of an academic referral center in the Middle East. (Abstract) 13th Intl Cancer Conf, Seattle, 1982.
  29. Salem PA, Issa P, Brihi E, Obeid S, Allam C, Tarraf F, Khalyl M. The cancer program at the American University of Beirut Medical Center -- A model for the establishment of future cancer programs in the Middle East. (Abstract) 13th Intl Cancer Conf, Seattle, 1982.
  30. Hannoun J, Habboubi N, Allam C, Khalyl M, Brihi E, Issa P, Salem PA. Large cell lymphoma presenting as primary breast cancer --A report of four cases. (Abstract) 13th Intl Cancer Conf, Seattle, 1982.
  31. Hashimi L, Anaissie E, Allam C, Khalyl M, Salem PA. Childhood abdominal lymphomas in the Middle East. (Abstract) 2nd Intl Conf on Malignant Lymphoma, Lugano, 1984.
  32. Anaissie E, Geha S, Allam C, Jabboury K, Obeid M, Issa P, Brihi E, Khalyl M, Shikhani A, Samara M, Salem PA. Waldeyer's Ring lymphomas -- A study of 83 cases from the Middle East. 2nd Intl Conf on Malignant Lymphoma, Lugano, 1984.
  33. Salem PA, Hashimi L, Anaissie E, Khalyl M, Allam C. Primary intestinal lymphoma of adults in the Middle East. (Abstract) 4th Mediterranean Conf of Chemo, Rhodes, 1984.
  34. Shikhani A, Anaissie E, Allam C, Salem PA, Samara M. Primary lymphoma of the salivary glands -- Report of 4 cases and review of the literature. Intl Conf on Head and Neck Cancer, Baltimore, 1984.
  35. Salem PA, Habboubi N, Anaissie E, Brihi E, Issa P, Abbas J, Khalyl M. Cis-dichlorodiammineplatinum (II) is effective in the treatment of anal squamous cell carcinoma. (Abstract) Am Soc Clin Oncol, 4:78, 1985.
  36. Annaissie E, Geha S, Allam C, Jabboury K, Hashimi L, Khalyl M, Salem PA. Non-Hodgkin's lymphoma in the Middle East. Am Assoc Cancer Res, Abstract #580, 26:147, 1985.
  37. Salem PA, Khalyl M, Jabboury K, Hashimi L. The 5-day continuous infusion of cisplatinum -- An update on toxicity pattern. (Abstract) 14th Intl Conf of Chemo, Kyoto, 1985.
  38. Salem PA, Allam C, Hashimi L, Anaissie E, Khalyl M. Immunoproliferative small intestine disease -- A disease of the Middle East and Mediterranean countries. (Abstract) 14th Intl Cancer Conf, Budapest, 1986.
  39. Anaissie E, Geha S, Allam C, Jabboury K, Hashimi L, Khalyl M, Salem PA. Primary extra-nodal lymphoma in the Middle East. (Abstract) 14th Intl Cancer Conf, Budapest, 1986.
  40. Salem PA: Immunoproliferative small intestine disease -- The only human lymphoma associated with a tumoral marker. 2 Congresso Internazionale Sui Markers Tumorali, Napoli, p. 63, 1986.
  41. Salem PA, Anaissie E, Geha S, et al. Primary extranodal lymphoma in the Middle East. (Abstract) 3rd Intl Conf on Malignant Lymphoma, Lugano, 1987.
  42. Salem PA. Immunoproliferative small intestinal disease: New concepts in pathology. (Abstract) Am Soc Clin Oncol, 6:244, 1987.
  43. Salem PA, Hashimi L, Allam C. Immunoproliferative small intestinal disease -- The only human lymphoma associated with a biological marker and a recognizable benign phase. Am Soc Clin Oncol, Abstract #A945, 7:244, 1988.
  44. Jabboury K, Hortobagyi G, Holmes FA, Frye D, Salem PA. Phase II gallium nitrate infusion in breast cancer. Am Assoc Cancer Res, Abstract #1446, 29:363, 1988.
  45. Salem PA, Zukiwski A, Bunn P, Robinson W, Lamb R, Benjamin RS, Spitler L, Scannon P, Ackerman S. Treatment of advanced metastatic melanoma using single dose murine monoclonal antibody ricin A chain immunotoxin using dose escalation. Phase I study. (Abstract) 1st Intl Symp on Immunotoxins, p. 55, 1988.
  46. Salem PA, Zukiwski A, Robinson W, Bunn P, Lamb R, Benjamin RS, Spitler L, Wedel N, Ackerman S. Treatment of advanced metastatic melanoma using single dose murine monoclonal antibody -- Ricin A chain immunotoxin using dose escalation. A phase I study. Am Assoc Cancer Res, Abstract #1147, 30:288, 1989.
  47. Salem PA, Zukiwski A, Benjamin RS, Wallace S, Levitt D, Mavligit G. Arterial infusion of interleukin-2 (IL-2) for treatment of hepatic metastases from GI leiomyosarcoma: Predisposition of hypersensitivity to iodine-containing media. Am Soc Clin Oncol, Abstract #1252, 8:322, 1989.
  48. Legha S, Papadopoulos N, Plager C, Usakewicz J, Salem PA, Nicaise C, Benjamin R. A comparative evaluation of the uroprotective effect of mercaptoethane sulfonate (MESNA) and N-acetylcysteine (NAC) in sarcoma patients treated with ifosfamide. Am Soc Clin Onc, Abstract #1205, 9:311, 1990.
  49. Linke KA, Benjamin RS, Evans HL, Salem PA, and Benjamin RS: Phase I-II study of IL-2 used as a continuous infusion in patients with metastatic melanoma. Am Assoc Cancer Res, Abstract #A1217, 31:176, 1990, and Am Soc Clin Onc, 9:217, 1990.
  50. Legha S, Fiana M, Plager C, Papadopoulos N, Salem PA, Benjamin RS. Phase I-II study of IL-2 used as a continuous infusion in patients with metastatic melanoma. Am Assoc Cancer Res, Abstract #1047, 31:176, 1990.
  51. Salem PA, Steiger S, Benjamin RS. Phase II study of THP-adriamycin (Pirarubicin) and DTIC in advanced soft tissue sarcomas. (Abstract) 3rd Intl Conf on Neo-adjuvant Chemotherapy, France, p 24, February 6-9, 1991.
  52. Vadhan-Raj S, Broxmeyer HE, Hittelman WN, Papadopoulos NE, Pager C, Salem PA, Gutterman JU, Benjamin RS. Abrogating chemotherapy CT-induced myelosuppression by GM-CSF: Optimizing the schedule. Am Soc Clin Oncol, Abstract #1241, 10:349, 1991.
  53. Salem PA, Steiger S, Benjamin RS. Phase II study of THP-Adriamycin (pirarubicin) and DTIC in advanced soft tissue sarcomas. Am Soc Clin Oncol, Abstract #1249, 10:351, 1991.
  54. Plager C, Papadopoulos NEJ, Salem PA, Benjamin RS. Adriamycin-based chemotherapy for leiomyosarcoma of the stomach and small bowel. Am Soc Clin Oncol, Abstract #1251, 10:352, 1991.
  55. Patel SR, Legha SS, Salem PA, Plager C, Papadopoulos NEJ, Benjamin RS. Evaluation of Ifosfamide in metastatic leiomyosarcomas of gastrointestinal (GI) origin. Am Soc Clin Oncol, Abstract #1252, 10:352, 1991.
  56. Salem PA, Benjamin RS, Howard J, Gutterman JU. Phase II trial of recombinant interferon alpha 2-b in the treatment of advanced metastatic and refractory sarcomas. Am Assoc Cancer Res, Abstract #1192, 32:200, 1991.
  57. Salem PA, El-Hashimi L, Anaissie E, Geha S, Habboubi N, Ibrahim N, Khalyl M, Allam C. Primary small intestinal lymphoma in adults. A comparative study of IPSID versus non-IPSID in the Middle East. 8th Mediterranean Congr of Chemo, Athens, J Chemother, May 24-29, 1992.
  58. Salem PA. Advances in the treatment of soft tissue sarcomas. 8th Mediterranean Congr of Chemo, Athens, J Chemother, May 24-29, 1992.
  59. Salem PA. The Emerging Role of Immunotherapy in the treatment of cancer. Keynote Speech. VIII ARTOI International Conference, New Frontiers of Integrated Oncology from Research to Integration. Florence, Italy November 11-13, 2016.
  60. Salem PA., Jabboury K, Stenoien R, Wheeler T, Valerio MR. Personalized Multimodality Therapy with Immune Checkpoint Inhibitors (ICI), Chemotherapy (CT), and Targeted Treatment (TT) in Advanced Refractory Cancer. Published as an abstract in the 2019 ASCO Annual Meeting Proceedings. Journal of Clinical Oncology, 37, #25 supplement. (e14254).
  61. Salem PA., Jabboury K, Stenoien R, Wheeler T. Personalized Multimodality Therapy with Immune Checkpoint Inhibitors (ICI), Chemotherapy (CT), and Targeted Treatment (TT) in Advanced Refractory Cancer. Published as an abstract in the 2020 ASCO Annual Meeting Proceedings. Journal of Clinical Oncology; volume 38; issue 15; S supplement. (e15150).